Administration of Chlorpromazine as a Treatment for COVID-19

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2020
In this study, defined cases of COVID-19 confirmed with PCR, with a mild, moderate or severe pneumonia will be treated with chlorpromazine. The improvement in clinical \& laboratory manifestations will be evaluated in treated patient compared to control group.
Epistemonikos ID: 582c0f83583aedb27438aad8c95ea5051e0f861e
First added on: Apr 22, 2020